Thursday, 02 April 2020

Japan News

  • Astellas Pharma launches new vaccine in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 06 Nov, 2012

    Singapore: Astellas Pharma has launched the combined vaccine for the prevention of pertussis, diphtheria, tetanus, and poliomyelitis (Quattrovac subcutaneous injection syringe), which is ma...Read more

  • Shimadzu launches gas chromatograph mass spectrometer

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 21 May, 2012

    Singapore: Shimadzu Corporation introduced the GCMS-TQ8030 ultra fast triple quadrupole gas chromatograph mass spectrometer, achieving the next step forward in Shimadzu's GC-MS history of i...Read more

  • Eisai pharma opens its new Australia division

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 11 Nov, 2014

    Singapore: Eisai, a Japanese pharmaceutical company, is seeking to expand its global network by opening a new office in Australia. The new outlet will serve as a platform to market Eisai's ...Read more

  • There must be another way'- thought iPS cell guru Shinya Yamanaka

    Japan |  Influencers | By Piyusha Chatterjee | 0 Comment | 25 Oct, 2012

    "When I saw the embryo, I suddenly realized there was such a small difference between it and my daughters. I thought, we can't keep destroying embryos for our research. There must be anothe...Read more

  • BioSpectrum Asia launches 5th CRO survey

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 30 Jul, 2013

    Singapore: After four consecutive successful annual surveys on the developments in the clinical research industry, BioSpectrum Asia has now launched the fifth annual survey of the contract ...Read more

  • Japan to launch emergency center in Cambodia

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 26 Dec, 2013

    Singapore: Innovation Network Corp. of Japan has announced its plans to establish a joint venture with two other Japanese companies in January to run an emergency medical center in Cambodia...Read more

  • LCT, Otsuka to co-develop NTCELL for Parkinson's

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 17 Dec, 2012

    Singapore: Living Cell Technologies have signed an agreement with Otsuka Pharmaceutical Factory to co-develop NTCELL for the treatment of Parkinson's disease and other neurological disorder...Read more

  • 10 pharma giants join hands to speed up drug discovery

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 18 Oct, 2012

    Collaboration has emerged as the preferred way forward for pharmaceutical companies looking to address the patent cliff, a drying product pipeline and challenges associated with R&D. To...Read more

  • Japanese biomedical firm sets up lab in Singapore

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 09 Sep, 2013

    Singapore: Japan-based biopharmaceutical firm, Kyowa Hakko Kirin (KHK) has setup Singapore Translational Research Laboratory (STRL), an international R&D center in Singapore for biomedi...Read more

  • Pharmacovigilance: A strategic opportunity

    Japan |  Opinion | By BioSpectrum Bureau  | 0 Comment | 06 Sep, 2012

    For many Asian pharmaceutical companies, pharmacovigilance is a critical component of any drug development program. As product safety continues to receive a high level of emphasis from regu...Read more

  • CEO of Takeda's Millennium Pharma quits abruptly

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 13 May, 2013

    Singapore: Ms Deborah Dunsire, CEO, Millennium Pharmaceuticals, is leaving the company in an abrupt departure. Ms Dunsire fueled the emergence of Millennium Pharma as a prominent force in c...Read more

  • Daiichi Sankyo reveals its five-year business plan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 22 Mar, 2013

    Singapore: Daiichi Sankyo has announced a new five-year business plan, which will span from April 1, 2013 through March 31, 2018. As part of the new plan, the company said it will work towa...Read more

  • Daiichi to work with US FDA to solve Ranbaxy quality issue

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 25 Sep, 2013

    Singapore: As a strong reaction to the import ban placed on Ranbaxy Laboratories' third manufacturing unit in India, the company's majority stakeholder, Daiichi Sankyo, has now made a state...Read more

  • Takeda gets go ahead for teduglutide in Europe

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 05 Sep, 2012

    Singapore: The European Commission (EC) has granted European market authorization for the medicinal product teduglutide (Revestive in Europe) as a once-daily treatment for adult patients wi...Read more

  • Astellas, UMN pharma to curb influenza in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 03 Jun, 2014

    Singapore: In a bid to curtail the growing cases of influenza in Japan, Astellas announced that it has submitted an application for marketing approval of recombinant influenza HA vaccine A...Read more

  • Big Pharma continues acquisitions

    Japan |  Analysis | By BioSpectrum Bureau  | 0 Comment | 19 Jun, 2012

    The first quarter of 2011 witnessed major deals in the global pharmaceutical space, with April proving to be a big month for M&A activity, with companies making transactions for more th...Read more

  • Ranbaxy aiming to sell its generics in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 18 Nov, 2013

    Singapore: Leading Indian generic drug maker, Ranbaxy Laboratories, along with its owners, Japan's second largest pharma company, Daiichi Sankyo has planned to supply medicines in Japan fro...Read more

  • Daiichi Sankyo and Asubio merge to streamline operations

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 05 Apr, 2015

    Daiichi Sankyo Inc., the US subsidiary of Daiichi Sankyo Company Ltd, will merge with its US-based sister company, Asubio Pharmaceuticals Inc. As a result, Asubio Pharmaceuticals, Inc. proj...Read more